AWM
FOLD

Arbor Wealth Management’s Amicus Therapeutics FOLD Stock Holding History

Arbor Wealth Management’s Portfolio FOLD Stock Details FOLD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-10,051
Closed -$121K – 191
2018
Q3 		$121K Sell
10,051
-375
-4% -$5.24K 0.1% 53
2018
Q2 		$144K Buy
+10,426
New +$158K 0.11% 55

Other funds holding FOLD

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Arbor Wealth Management's FOLD Position: Q4 2018 in Review

Arbor Wealth Management sold out of Amicus Therapeutics (FOLD) in Q4 2018, closing a stake of 10,051 shares — an estimated $121K sold.

Arbor Wealth Management first reported a position in FOLD in Q2 2018 and held it in 2 quarters. The position peaked at $144K in Q2 2018. 195 funds tracked by Wall St. Rank hold FOLD as of Q4 2018.

  • Arbor Wealth Management reported no remaining Amicus Therapeutics position as of Q4 2018 after selling out during the quarter.
  • Arbor Wealth Management sold 10,051 Amicus Therapeutics shares in Q4 2018, an estimated $121K.
  • Arbor Wealth Management first reported a position in Amicus Therapeutics in Q2 2018 and held it in 2 quarters.
  • Arbor Wealth Management's Amicus Therapeutics position peaked at $144K in Q2 2018.
  • 195 funds tracked by Wall St. Rank held Amicus Therapeutics as of Q4 2018.

Based on Arbor Wealth Management's 13F filing for Q4 2018, filed 11 Mar 2019.